Product correctly added to cart.

discount label
Adefovir-D4
View 3D

Biosynth logo

Adefovir-D4

CAS: 1190021-70-5

Ref. 3D-FA07177

1mgTo inquire
2mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
Estimated delivery in United States, on Wednesday 8 Jan 2025

Product Information

Name:
Adefovir-D4
Synonyms:
  • [[2-(6-Amino-9H-purin-9-yl-D4)ethoxy]methyl]phosponic acid
Description:

Adefovir-D4 is a prodrug that is metabolized by the liver to its active form, adefovir. Adefovir-D4 is used as a treatment for chronic hepatitis B virus (HBV) infection. It may be used in combination with pegylated interferon alfa-2a and ribavirin. Adefovir-D4 has been shown to inhibit the growth of renal epithelial cells and reduce the production of nephrotoxins. The pharmacokinetic profile of this drug has been studied in detail and it is known that it binds to proteins after intravenous administration, which causes an increase in its plasma concentration. This drug also has a chromatographic profile, which can be useful for measuring plasma concentrations in patients with renal impairment.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
277.21 g/mol
Formula:
C8H8D4N5O4P
Purity:
Min. 95%
Color/Form:
White To Off-White Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FA07177 Adefovir-D4

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".